UBS Group’s Averin Capital Acquisition Corp ACAA Stock Holding History

UBS Group’s Portfolio ACAA Stock Details ACAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Buy	+2	New	+$20	﹤0.01%	10283

Other funds holding ACAA

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

UBS Group's ACAA Position: Q2 2026 in Review

UBS Group opened a new position in Averin Capital Acquisition Corp (ACAA) in Q2 2026: 2 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #10283 among its holdings.

40 funds tracked by Wall St. Rank hold ACAA as of Q2 2026.

UBS Group held 2 shares of Averin Capital Acquisition Corp worth $20 as of Q2 2026.
Averin Capital Acquisition Corp was a new UBS Group position in Q2 2026.
Averin Capital Acquisition Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10283 holding.
40 funds tracked by Wall St. Rank held Averin Capital Acquisition Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.